PropThink to Host Special Conference Call With Sunshine Heart CEO

PropThink to Host Special Conference Call With Sunshine Heart CEO 
Investors Are Invited to Dial-In and Participate in an Exclusive
Conference Call With Sunshine Heart CEO David Rosa; Free Registration
on PropThink.com Is Required to Join 
NEW YORK, NY -- (Marketwired) -- 08/28/13 --  PropThink.com
("PropThink"), a leading healthcare-focused provider of investment
research and analysis, will host an interview and investor Q&A
conference call with David Rosa, Chief Executive Officer at Sunshine
Heart, Inc. (NASDAQ: SSH), on Tuesday, September 3rd, 2013 at 3:00 PM
EDT.  
The call is open to all investors who complete a free registration on
PropThink.com. Further instructions are available by visiting
PropThink.com/SunshineHeartCall or by clicking here. 
Why We're Interviewing Sunshine Heart 
Shares of Sunshine Heart have appreciated significantly in the past
four months, up over 140% since the company's mid-April capital
raise, as healthcare investors have taken particular note of this
small-cap medical device developer. Sunshine Heart's developmental
C-Pulse Heart Assist device offers a novel approach to the treatment
of late-stage congestive heart failure, and an early feasibility
study completed in 2011 demonstrated that the device provided a
strong benefit in a historically difficult-to-treat patient
population. Heart failure patients in the early study have seen the
severity of their disease improve drastically with time on the
device, so much so in fact, that C-Pulse is arguably reversing the
latter stages of congestive heart failure -- two of 20 patients have
already been weaned from the product, and Sunshine Heart is
evaluating more patients for complete removal of the implanted heart
assist system. Now, a large pivotal trial being run in the United
States and a second, smaller trial running concurrently in Europe are
designed to bring the device through the approval process, and
subsequently, to the thousands of patients suffering from late-stage
heart failure in the U.S. and Europe. 
How To Participate 
1. Investors interested in participating in this PropThink-hosted
event will need to register by visiting
PropThink.com/SunshineHeartCall or by clicking here. Registration is
open to all investors free of charge.  
2. Registrants will receive a confirmation email with dial-in
instruction 24 hours prior to the conference call. Participating
investors will have the ability to ask Sunshine Heart's Chief
Executive David Rosa questions following the interview portion of the
call -- the operator will provide instructions on how to jump in
queue for questions during the call.  
Questions about the conference call can be directed to
editor@propthink.com. 
About PropThink 
PropThink is an intelligence service that delivers long and short
trading ideas to investors in the healthcare and life sciences
sectors. Our focus is on identifying and analyzing technically
complicated companies and equities that are grossly over- or
under-valued. We offer daily market coverage, weekly feature stories,
and a newsletter to investors who subscribe on PropThink.com. To
learn more, follow us on Twitter or visit us at
http://www.propthink.com. In addition, PropThink is offering
investors 30 days of free access to a premium intelligence service
designed to empower individual investors by providing actionable,
timely, and accurate research on companies and investment
opportunities in the healthcare sector. 
PropThink 
editor@propthink.com 
 
 
Press spacebar to pause and continue. Press esc to stop.